Description: Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. The Cardiac and Vascular Group's products include pacemakers; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management (CRDM) devices; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery devices for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder (OCD), overactive bladder, urinary retention, and fecal incontinence and gastroparesis; external insulin pumps; subcutaneous CGM systems; products to treat conditions of the ear, nose, and throat; and devices that incorporate advanced energy technology. It also manufactures and sells image-guided surgery and intra-operative imaging systems; and provides Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.
Home Page: www.medtronic.com
MDT Technical Analysis
20 On Hatch
Dublin,
2
Ireland
Phone:
353 1 438 1700
Officers
Name | Title |
---|---|
Mr. Geoffrey Straub Martha | Chairman & CEO |
Ms. Karen L. Parkhill | EVP, CFO, IT & Enterprise Excellence |
Mr. Ivan K. Fong | Exec. VP, Gen. Counsel & Sec. |
Mr. Robert J. W. ten Hoedt | Exec. VP & Pres of Global Regions |
Mr. Robert John White | Exec. VP & Pres of Medical Surgical Portfolio |
Mr. Mark Ploof | Sr. VP of Global Operations and Bus. Services |
Ms. Jennifer M. Kirk | Principal Accounting Officer, Global Controller & Chief Accounting Officer |
Dr. Laura Mauri M.D., M.Sc. | Sr. VP and Chief Scientific, Medical & Regulatory Officer |
Mr. Sean Lennon | Chief Information Officer |
Mr. Ryan Weispfenning | VP of Investor Relations |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 14.881 |
---|---|
Trailing PE: | 24.5 |
Price-to-Book MRQ: | 2.0201 |
Price-to-Sales TTM: | 3.3559 |
IPO Date: | 1978-01-13 |
Fiscal Year End: | April |
Full Time Employees: | 95000 |